Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Attenuation of cerebral edema facilitates recovery of glymphatic system function after status epilepticus
Kewei Liu, Juan Zhu, Yuan Chang, Zhenzhou Lin, Zhu Shi, Xing Li, Xing Chen, Chuman Lin, Suyue Pan, Kaibin Huang
Kewei Liu, Juan Zhu, Yuan Chang, Zhenzhou Lin, Zhu Shi, Xing Li, Xing Chen, Chuman Lin, Suyue Pan, Kaibin Huang
View: Text | PDF
Research Article Neuroscience Therapeutics

Attenuation of cerebral edema facilitates recovery of glymphatic system function after status epilepticus

  • Text
  • PDF
Abstract

Status epilepticus (SE) is a neurological emergency usually accompanied by acute cerebral edema and long-term cognitive impairment, and is characterized by neurodegeneration and aberrant hyperphosphorylated tau protein (p-tau) aggregation. The glia-lymphatic (glymphatic) system plays a central role in facilitating the clearance of metabolic waste from the brain, but its relationship with cerebral edema and cognitive dysfunction after SE is unclear. We hypothesized that cerebral edema after SE might impair glymphatic system function through compression, thus leading to impaired removal of metabolic waste, and ultimately affecting long-term cognitive function. Our results showed that glymphatic system function was temporarily impaired, as evidenced by 2-photon imaging, MRI enhancement, imaging of brain sections, and astrocytic water channel aquaporin 4 (AQP4) protein polarization. The severity of cerebral edema on MRI correlated well with glymphatic system dysfunction within 8 days following SE. Moreover, when cerebral edema was alleviated by glibenclamide treatment or genetic deletion of Trpm4, post-SE glymphatic system function recovered earlier, along with fewer p-tau–deposited neurons and neuronal degeneration and better cognitive function. These findings suggest that SE-induced cerebral edema may cause glymphatic system dysfunction and render the post-SE brain vulnerable to p-tau aggregation and neurocognitive impairment.

Authors

Kewei Liu, Juan Zhu, Yuan Chang, Zhenzhou Lin, Zhu Shi, Xing Li, Xing Chen, Chuman Lin, Suyue Pan, Kaibin Huang

×

Figure 5

Interstitial solute drainage is temporarily impaired after SE.

Options: View larger image (or click on image) Download as PowerPoint
Interstitial solute drainage is temporarily impaired after SE.
(A) Schem...
(A) Schematic depiction of intrastriatal injection of OVA-555 (+1.5 mm AP, +1.5 mm ML, –2.5 mm DV from bregma). (B) Representative images of OVA-555 residue in the brain (6 brain sections). Scale bar: 2000 μm. (C) Representative images of the fluorescence intensity of OVA-555 drainage into the dCLNs. Scale bar: 500 μm. (D) Quantitative analysis of the percentage area of fluorescence in the 6 brain sections (n = 6 each). (E) Quantitative analysis of fluorescence intensity in the dCLNs (n = 6 each). Data are shown as the mean ± SD. Differences within multiple groups were examined by 1-way ANOVA with Bonferroni’s multiple comparison test. ****P < 0.0001 versus saline control group; #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001 versus 3 days after SE.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts